Hereditary angioedema: Quality of life in Brazilian patients

Clinics

Volumn 68, Issue 1, 2013, Pages 81-83

  Gomide, Maria Abadia Consuelo M S ^a   Toledo, Eliana ^b   Valle, Solange Oliveira Rodrigues ^c   Campos, Regis A ^d   França, Alfeu T ^c   Gomez, Nieves Prior ^e   Andrade, Heitor Franco ^a   Caballero, Teresa ^e   Grumach, Anete S ^a,f  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b São José do Rio Preto Medicine School   (Brazil)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^d FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^e HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^f FACULDADE DE MEDICINA DO ABC   (Brazil)

Author keywords

Asphyxia; Hereditary angioedema; Quality of life; Questionnaires; SF 36

Indexed keywords

EID: 84874131674     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.6061/clinics/2013(01)OA13     Document Type: Article

References (11)

1. Davis AE 3rd, Medja P, Lu F. Biological activities of C1-Inhibitor. Mol Immunol. 2008;45(16):4057-63, http://dx.doi.org/10.1016/j.molimm. 2008.06.028.
2. Bowen T, Cicardi M, Bork K, Zuraw B, Frank M, Ritchie B, et al. Hereditary angioedema:a current state of the art review, VII: Canadian Hungarian 2007 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema. Ann Allergy Asthma Immunol. 2008;100(1 Suppl 2):S30-40, http://dx.doi.org/10. 1016/S1081-1206(10)60584-4.
3. Agostoni A, Aygoren-Pursun E, Binkley KE, Blanch A, Bork K, Bouillet L, et al. Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. J Allergy Clin Immunol. 2004;114(3 Suppl):S51-131, http://dx. doi.org/10.1016/j.jaci.2004.06.047.
4. Bowen T, Cicardi M, Farkas H, Bork K, Longhurst HJ, Zuraw B, et al. 2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema. Allergy Asthma Clin Immunol. 2010;6(1):24-36, http://dx.doi.org/10.1186/1710-1492-6-24.
5. Ciconelli RM, Ferraz MB, Santos W, Meinão I, Quaresma MR. Tradução para a língua portuguesa e validação do questionário genérico de avaliação da qualidade de vida SF-36. Rev. Bras. Reumatol. 1999;39(3):143-50.
6. Lumry WR, Castaldo AJ, Vernon MK, Blaustein MB, Wilson DA, Horn PT. The humanistic burden of hereditary angioedema: impact on healthrelated quality of life, productivity, and depression Allergy Asthma Proc. 2010;31(5):407-14.
7. Poon E, Seed PT, Greaves MW, Kobza-Black A. The extent and nature of disability in different urticarial conditions. Br J Dermatol. 1999;140(4):667-71.
8. Bygum A, Andersen KE, Mikkelsen CS. Self-administration of intravenous C1-inhibitor therapy for hereditary angioedema and associated quality of life benefits. Eur J Dermatol. 2009;19(2):147-51.
9. Bradlyn AS, Ritchey AK, Harris CV, Moore IM, O'Brien RT, Parsons SK, et al. Quality of life research in pediatric oncology. Research methods and barriers. Cancer. 1996;78(6):1333-9, http://dx.doi.org/10.1002/(SICI)1097-0142(19960915)78:6,1333::AID-CNCR24.3.0.CO;2-0.
10. Both H, Essink-Bot ML, Busschbach J, Nijsten T. Critical review of generic and dermatology-specific health-related quality of life instruments. J Invest Dermatol. 2007;127(12):2726-39, http://dx.doi.org/10. 1038/sj.jid.5701142.
11. Prior N, Remor E, Gómez-Traseira C, López Serrano C, Cabañas R, Contreras J, et al. Development of a disease-specific quality of life questionnaire for adult patients with hereditary angioedema due to C1 inhibitor deficiency (HAE-QOL): Spanish multi-centre research project. Health Qual Life Outcomes. 2012;10(1):82, http://dx.doi.org/10.1186/1477-7525-10-82.